Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...
Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.
At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...
We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Tariff Chaos. In this article, we are going to take a look at where The Campbell’s Company (NASDAQ:CPB) stands against ...
Last week, we heard about how beverage giant PepsiCo (PEP) was looking to pick up the probiotic soft drink brand Poppi in a bid to keep its ...
It’s hard to turn on the TV these days without seeing ads for drugs like Ozempic, Wegovy, Zepbound or Mounjaro. These ...
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Florastor, the world's No. 1 selling probiotic strain with 70 years of trusted research and effective use, is launching a new ...
Ready to reclaim your digestive wellness? With a carefully crafted blend of gut-friendly bacteria, Feel Pro Metabolic helps ...
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Longevity doctor reveals common Ozempic mistakes affecting adults over 50, including protein deficiency, mental health risks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results